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OBJECTIVES We tested the hypothesis that the reperfusion syndrome (RS), defined as an additional
elevation of the ST segment upon reperfusion, may be a marker of microcirculatory
reperfusion injury during acute myocardial infarction (AMI).
BACKGROUND The pathophysiology of the RS is unknown, and its prognostic implications are controversial.
METHODS Twenty-one patients with an anterior AMI treated #12 h after onset by primary coronary
angioplasty (PTCA) were studied. Coronary velocity reserve (CVR), an index of microcir-
culatory function, was measured using a Doppler guidewire. Left ventricular (LV) ejection
fraction, infarct size (percent defect) and LV end-systolic volume index (LVESVi) were
evaluated by radionuclide ventriculography, 201T1 single-photon emission computed tomog-
raphy and contrast ventriculography, respectively.
RESULTS Baseline ST elevation and pain-to-TIMI 3 time were similar in patients with and without RS.
Patients with RS (10/21) had a lower post-PTCA CVR than patients without RS (median
[95% confidence interval]: 1.2 [1–1.3] vs. 1.6 [1.5–1.7], p , 0.005). Even though
predischarge CVR was similar in the two groups, infarct size at six weeks (26 [21 to 37] vs.
14 [10–17] % 201T1 defect, p 5 0.001) and predischarge LVESVi (45% [40 to 52] vs. 30%
[29 to 38] mL/m2, p 5 0.001) were larger, and LV ejection fraction at six weeks (40% [37
to 46] vs. 55% [50 to 60], p 5 0.004) was lower in patients with RS than in patients without
RS.
CONCLUSIONS Patients with RS during primary PTCA for an anterior AMI have a transiently lower CVR
than patients without RS, but sustained LV dysfunction and larger infarct size, suggesting
that RS is a marker of microcirculatory reperfusion injury. (J Am Coll Cardiol 2000;35:
1162–9) © 2000 by the American College of Cardiology
In a substantial subset of patients with acute myocardial
infarction (AMI), timely revascularization fails to salvage
ischemic myocardium (1). This unfavorable outcome stems
from a discrepancy between an open epicardial infarct-
related coronary artery and the absence of blood flow
(no-reflow) in the damaged distal microvessels (2). The aim
of this study was to determine whether a reperfusion
syndrome (RS), defined as an acute additional elevation of
the ST segment upon reperfusion (3–9), is a marker of
impaired reperfusion. Coronary velocity reserve (CVR), an
index of microcirculation integrity, was measured in patients
with and without RS after primary percutaneous translumi-
nal coronary angioplasty (PTCA) for an anterior AMI. We
tested the hypotheses that patients with RS would have: 1)
lower post-PTCA CVR, and 2) more extensive myocardial
infarction and worse left ventricular (LV) function at
follow-up.
METHODS
Patient population. The study population comprised 21
patients referred to the Coronary Care Unit #12 h after
onset of an anterior AMI and who underwent primary
PTCA. Only patients with total occlusion (i.e., Thrombol-
ysis in Myocardial Infarction (TIMI) grade 0 or 1 flow) of
the proximal or midleft anterior descending coronary artery
(LAD) were included. Patients with prior AMI, cardiogenic
shock or potential alteration of microcirculatory function
due to a history of diabetes mellitus or severe LV hypertro-
phy were excluded. In order to prevent heterogeneous
collection of flow velocity data, the same operator (L.J.F.)
performed all the Doppler analyses, and, hence, patients
were not consecutively included. The study protocol was
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approved by the Human Research Committee of the Insti-
tutional Review Board, and patients gave their informed
consent before inclusion.
Electrocardiographic analysis. Two electrocardiograms
(ECGs) were analyzed. The first ECG was obtained im-
mediately before angioplasty (TIMI 0 flow) and the second
#2 min after recanalization of the infarct-related artery
(TIMI 3 flow). Patients were classified into two groups
depending upon presence or absence of RS, defined as an
increase of $5 mm in the sum of ST segment elevation,
measured at the J point in leads I, aVL and V1–V6 (7). The
isoelectric line was defined as the preceding PR segment.
Patients with new right or left bundle branch block or
persistent ventricular arrhythmia were excluded.
Coronary balloon angioplasty. Each patient received
$250 mg aspirin and heparin (100 IU/kg IV) before
PTCA. Percutaneous transluminal coronary angioplasty was
performed using a 0.014-in Doppler-tipped guidewire
(FloWire, Endosonics Rancho Cordova, California). Pro-
cedural success was defined as TIMI 3 flow and ,50%
residual stenosis. Coronary artery dissections were graded
according to National Heart, Lung and Blood Institute
classification (10). Stents were implanted in case of unsat-
isfactory result or preprocedural acute reocclusion. Stented
patients received ticlopidine (250 mg twice a day) and
aspirin (100 mg), whereas nonstented patients were given
aspirin (250 mg) only. Each patient underwent predischarge
coronary angiography.
Quantitative coronary angiography and measurement of
LV volumes. Quantitative coronary angiography was per-
formed using the Philips DCI system. Arterial diameter at
the angioplasty site was measured on end-diastolic frames.
Two orthogonal projections were used to compute the
minimal lumen diameter (MLD) and the percent diameter
stenosis. The guiding catheter was used as a scaling device.
Collateral vessels were graded according to Rentrop’s clas-
sification (11). Left ventricular end-systolic volume index,
an independent predictor of early and late mortality after
AMI (12), was evaluated according to the area-length method,
using LV angiograms obtained in the 30° right anterior oblique
projection during predischarge angiography.
Coronary flow velocity reserve measurements. Blood
flow velocity was measured after angioplasty and during
predischarge angiography using the Doppler guidewire
connected to a real-time spectrum analyzer (FloMap, En-
dosonics), as described (13). The Doppler tip was posi-
tioned at a distance $5 times the vessel diameter distal to
the angioplasty site to avoid poststenotic turbulence. Veloc-
ity sampling was repeated in the same arterial segment at
the predischarge study. Flow-dependent dilatation of epi-
cardial coronary arteries was abolished by intracoronary
injection of 1 mg linsidomine.
Time-averaged peak velocity (APV) was computed on-
line and continuously recorded on videotape. Coronary
velocity reserve was calculated as the ratio of hyperemic to
resting APVs (APVpeak/APVbase) after intracoronary injec-
tion of 18 mg adenosine (14). Because postreperfusion
hyperemic flow may result in underestimation of CVR,
measurements were performed only when APV had reached
a plateau for $10 min, without cyclic flow variations, as
indicated by the recording of velocity trends (15). Measure-
ments were repeated until 2 consecutive CVR determina-
tions varied by #10%. In each patient, CVR was also
measured in an angiographically normal coronary artery.
Determination of myocardial infarct size and LV ejection
fraction. Measurements of total creatine kinase activity
(normal value ,295 IU/L) were performed every 6 h for
48 h after PTCA. Infarct size was first approximated by
peak creatine kinase activity, then measured by the postin-
jection percentage 201T1 defect; on rest 201T1 single-photon
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Table 1. Baseline Clinical Characteristics
RS No RS p Value
N (%) 10 (47.6) 11 (52.3)
Male gender (n, [%]) 7 (70) 7 (63.6) NS
Age (yr) 63.5 (52.1–71.3) 59 (47.4–67) NS
Pain-to-CCU time (min) 198 (151–316) 250 (191–300) NS
Exacerbation of pain at reperfusion
(n, [%])
10 (100) 1 (9.1) ,0.005
SST pre-PTCA (mm) 14.5 (9.6–18.2) 13 (9.5–16.6) NS
SST #2 min post-PTCA (mm) 25 (18.9–29.7) 10 (7.5–13.1) ,0.001
CCU 5 coronary care unit; RS 5 reperfusion syndrome; SST 5 sum of ST-segment elevation.
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emission computed tomography performed six weeks after
AMI (16). Radionuclide LV ejection fraction was measured
six weeks after AMI (17).
Statistical analysis. Continuous variables are expressed as
medians (95% confidence interval). Intergroup comparisons
of continuous variables at day 0 were performed by one-way
analysis of variance. Inter- and intragroup comparisons of
hemodynamic and blood flow velocity data required a
two-way repeated measures analysis of variance, which
tested the effects of group (RS vs. no RS), time (post-PTCA
vs. predischarge) and the interaction of both on these
variables. If the global test showed a significant effect or
interaction, post hoc unpaired or paired Student t tests were
performed for intergroup and intragroup comparisons, re-
spectively. Categorical variables were analyzed by the chi-
square test. Relation between Rentrop score and post-PTCA
CVR was determined by regression analysis. All statistical
analyses were performed with the SAS V6.12 software. A value
of p , 0.05 was considered statistically significant.
RESULTS
Clinical characteristics. An ECG pattern suggestive of
RS, which was always associated with an exacerbation of
chest pain, was found in 10 of 21 patients. Clinical character-
istics of patients with and without RS were similar (Table 1).
PTCA and angiographic data. All the patients had TIMI
0 or 1 flow before PTCA. Collateral flow to the ischemic
myocardium was significantly lower in patients with RS
(Table 2). Percutaneous transluminal coronary angioplasty
Table 2. Angiographic Data During Primary PTCA
RS no RS p Value
Multivessel disease (n, [%]) 4 (40) 5 (45.4) NS
Collateral flow (Rentrop grade) 0 (0–0.8) 1 (0.8–1.7) 0.003
Reference segment diameter (mm) 3.1 (2.9–3.3) 3 (2.8–3.1) NS
MLD post-PTCA (mm) 2.6 (2.1–2.9) 2.5 (2.3–2.6) NS
Percent stenosis post-PTCA 14.5 (9.7–28.4) 14 (9.5–22) NS
Stent implantation (n, [%]) 6 (60) 6 (54.5) NS
Angiographic complications (n, [%]):
Angiographic no- or low-reflow 1 (10) 0 NS
Distal embolism 2 (20) 2 (18.2) NS
Dissection (grade . B*) 3 (30) 4 (36.4) NS
Acute reocclusion 2 (20) 1 (9.1) NS
Time from pain to TIMI 3 flow
(min)
290 (212–393) 320 (242–341) NS
*Dissection protruding outside the lumen of the vessel and persisting after passage of the contrast material.
MLD 5 minimal lumen diameter; RS 5 reperfusion syndrome.
Table 3. Hemodynamic and Flow Velocity Data
Heart Rate
(/min)
Mean ABP
(mm Hg)
APVbase
(cm/s)
APVpeak
(cm/s)
CVR
Infarct-Related
Artery
CVR
Normal
Artery
RS
Post-PTCA 82.5 (80–91) 93.5 (89.3–104) 16.5 (13.8–20.8) 22.5 (17–26) 1.2 (1–1.3) 2 (1.7–2.2)
\
Predischarge 64 (60–74.7) 87 (78–91) 17 (14.3–21-3) 36 (28.6–40.3) 1.8 (1.7–2.2) 2.8 (2.2–3.4)
* † * * †¶
no RS
Post-PTCA 85 (76–89) 90 (85.2–102.6) 16 (13.4–21.8) 26 (22.2–32.7) 1.6 (1.5–1.7) 2.2 (1.9–2.5)
‡ § \
Predischarge 60 (57.5–66) 80 (76–94.4) 18 (14–18.5) 32 (28–38.5) 2 (1.9–2.2) 3 (2.7–3.1)
* † *\
2-Way ANOVA (p Values)
Group effect 0.2 0.8 0.7 0.03 ,0.005 0.3
Time effect ,0.005 0.01 0.1 ,0.005 ,0.005 ,0.005
Interaction 0.6 0.6 0.5 0.01 0.03 0.6
*p , 0.005 vs. post-PTCA; †p 5 0.01 vs. post-PTCA; ‡p 5 0.05 vs. RS; §p , 0.005 vs. RS; \p , 0.005 vs. infarct-related artery; ¶p 5 0.02 vs. infarct-related artery.
ABP 5 arterial blood pressure; APV 5 time-averaged peak velocity; CVR 5 coronary velocity reserve; RS 5 reperfusion syndrome.
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was successful in each case, resulting in similar residual
stenoses and MLDs in the two groups. Transient acute
reocclusion occurred in two patients with RS and one
without RS, in each case .10 min after initial reperfusion.
Coronary stents were implanted in a similar proportion of
patients with and without RS. No antiglycoprotein IIb/IIIa
agent was used. Predischarge coronary angiography was
performed in each patient except one with RS, who died of
LV rupture 24 h after PTCA. The median intervals
between initial and predischarge angiographies were seven
days in both groups. No patient had silent reocclusion or
early restenosis (.50% stenosis at the target site). Residual
stenoses at the target site were 14% (6 to 23) and 13% (10
to 19) in patients with and without RS, respectively.
Hemodynamic and coronary flow velocity data. Coronary
flow velocity decreased progressively after reperfusion, then
reached a plateau, without detectable cyclic flow variations.
The hemodynamic and flow velocity variables, at steady
state after PTCA and at predischarge follow-up, are shown
in Table 3. At each time point, hemodynamic variables were
similar in patients with and without RS. However, in each
group, heart rate and mean arterial blood pressure signifi-
cantly decreased over time.
Although post-PTCA CVR in the infarct-related coro-
nary artery was severely depressed in both groups, CVR was
significantly lower in patients with RS. Representative
examples are depicted in Figures 1 and 2. The lower CVR
in patients with RS was related to significantly lower
hyperemic velocities, whereas resting velocities were similar
in the two groups. Overall, post-PTCA CVR correlated
positively with initial Rentrop score (p 5 0.001, R 5 0.6).
There was a marked effect of time (p , 0.005) and a
significant group (RS vs. no RS) by time (post-PTCA vs.
predischarge) interaction (p 5 0.03) on CVR in the
infarct-related artery. Indeed, in both groups, predischarge
CVR was significantly higher than post-PTCA CVR.
However, percent increase in CVR was higher in patients
with RS (66.7% [54–87.2] vs. 31.6% [20.5–38.1], p ,
0.005), and, hence, predischarge CVR was similar in the
two groups. Improvement of CVR over time was related to
a significant increase in hyperemic velocities in patients with
RS (Fig. 3).
Figure 1. ECG and coronary flow patterns in a patient with reperfusion syndrome. Primary PTCA of the mid-LAD was performed
245 min after the onset of chest pain. Panel A: Electrocardiogram pattern. Thirty s after reperfusion, the patient complained of increased
chest pain. The ECG obtained at that moment shows additional elevation of ST segment in leads V2 to V4: sum of ST segment elevation
(SST) increased from 13 to 31 mm. Panel B: Flow velocity pattern in the distal LAD 10 min after successful PTCA. On-line flow velocity
spectrum and time-averaged peak velocity (APV) are displayed on the top screen. Bottom left and right screens indicate base (BAPV 5
19 cm/s) and adenosine-induced hyperemic (PAPV 5 26 cm/s) APVs, respectively. Residual coronary velocity reserve (RATIO) is 1.3.
ECG 5 electrocardiogram; LAD 5 left anterior descending coronary artery; PTCA 5 percutaneous transluminal coronary angioplasty.
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Control CVR, measured in an angiographically normal
coronary artery, was not different in the two groups.
However, control CVR was higher than CVR in the
infarct-related artery at each time point and in both groups.
In addition, there was a significant effect of time (p ,
0.005) on control CVR, which was higher at predischarge
than post-PTCA (Table 3).
Infarct size and LV function. Peak creatine kinase activity
was higher in patients with RS than in patients without RS
(5,550 [4,653–6,452] vs. 3,500 [2,021–4,127] IU/L, p 5
0.001). Similarly, the actual infarct size, measured six weeks
after AMI by the postinjection percentage 201T1 defect, was
larger in patients with RS (Fig. 4). In addition, radionuclide
LV ejection fraction six weeks after AMI was significantly
lower, and predischarge LV end-systolic volume index was
markedly larger in patients with RS.
In-hospital complications. One patient with RS died
from LV rupture 24 h after PTCA. Six of 10 patients with
RS, but only 2 of 11 without RS, experienced $1 episode of
in-hospital congestive heart failure (Killip grade $2, p 5
0.05).
DISCUSSION
In this study: 1) a reperfusion syndrome was noted in 48%
of patients with an anterior AMI who were revascularized
using primary PTCA, 2) post-PTCA CVR was more
severely depressed in patients with RS than in patients
without RS, 3) although transient, the more severe alter-
ation of CVR in patients with RS was associated with more
in-hospital episodes of heart failure, larger myocardial
infarcts and greater depression of LV function.
ST changes during myocardial reperfusion. The poor
prognosis associated with persistent ST segment elevation
after primary angioplasty has been recently emphasized
(18,19). In contrast, the prognostic value of acute exacerba-
tion of ST segment elevation upon reperfusion (i.e., RS) is
unclear. Even though patients with RS during successful
thrombolysis (4–6,20) as well as PTCA (7–9) may be at
Figure 2. Electrocardiogram and coronary flow patterns in a patient without reperfusion syndrome. Primary PTCA of the mid-LAD was
performed 255 min after the onset of chest pain. Panel A: Electrocardiogram pattern. The patient experienced a gradual decline of chest
pain. The ECG obtained 1 min after reperfusion shows a partial resolution of ST segment elevation in leads V1 to V4: sum of ST segment
elevation (SST) decreased from 14 to 4 mm. Panel B: Flow velocity pattern in the distal LAD 10 min after successful PTCA. On-line
flow velocity spectrum and time-averaged peak velocity (APV) are displayed on the top screen. Bottom left and right screens indicate base
(BAPV 5 17 cm/s) and adenosine-induced hyperemic (PAPV 5 35 cm/s) APVs, respectively. Residual coronary velocity reserve
(RATIO) is 2.0. ECG 5 electrocardiogram; LAD 5 left anterior descending coronary artery; PTCA 5 percutaneous transluminal
coronary artery.
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particularly high risk of developing large infarcts and severe
LV dysfunction, this issue is still debated (3).
Pathophysiology of the reperfusion syndrome. It is un-
likely that acute reocclusion or distal emboli account for RS,
because, in our study, these angiographic complications
were infrequent and occurred with a similar incidence in
patients with and without RS. Moreover, cyclic variations of
flow velocity, an indicator of transient episodes of reocclu-
sion (15), were not observed in patients with RS. Kern et al.
(21) have recently described a broad spectrum of coronary
flow velocities in AMI patients with stable TIMI 3 flow
after primary PTCA, with a higher incidence of recurrent
ischemia in patients with velocities #20 cm/s. In this study,
however, post-PTCA flow velocity was similar in patients
with and without RS. Hence, the heterogeneity flow veloc-
ity after reperfusion is not a major determinant of RS.
Reperfusion syndrome and microcirculatory dysfunction.
One of the main findings of this study was that patients
with RS had a lower post-PTCA CVR than patients
without RS. Coronary flow reserve decreased after myocar-
dial ischemia/reperfusion (22). Recently, several investiga-
tors using intracoronary Doppler catheters (23,24), Doppler
guidewires (21,23,25,26), videodensitometry (27) or positon
emission tomography (28) have consistently reported in
AMI patients a markedly depressed flow reserve in the
infarct zone, despite an angiographically successful revascu-
larization.
The lower post-PTCA CVR observed in patients with
RS may be the consequence of larger myocardial infarction
and more extensive destruction of resistive arterioles. How-
ever, the fact that, in these patients, CVR improved by
;70% a few days after reperfusion and reached a level
similar to that found in patients without RS does not
support this hypothesis.
Alternatively, the transiently lower CVR in patients with
RS may reflect microvascular reperfusion injury (29). Mi-
crovascular types of reperfusion injury include the no-reflow
phenomenon (22) as well as an impairment of the micro-
circulatory function without obstruction to blood flow (30).
It is unknown which of these two mechanisms is predom-
inantly involved in the dramatic reduction of CVR observed
in patients with RS. However, the specific flow patterns of
no-reflow after primary PTCA (31) were not observed in
patients with RS, suggesting that transient microcirculatory
dysfunction prevails.
What may predispose patients to RS is unclear. Baseline
characteristics were similar in the two groups, except for
collateral flow, which was more preserved in patients with-
out RS. Whether collateral flow to the infarct zone prevents
reperfusion-related microcirculatory dysfunction and related
RS is unknown; however, the positive correlation between
Rentrop grade and post-PTCA CVR favors this hypothesis.
Figure 3. Variation in individual flow velocities over time. Indi-
vidual time-averaged peak velocities (APVs) under basal condi-
tions (base) and adenosine-induced hyperemia (peak), after PTCA
and at predischarge follow-up. Panel A: In patients with reperfu-
sion syndrome (RS), basal APV is stable over time whereas
hyperemic APV improves significantly. Panel B: Basal APV is
stable over time, whereas peak APV does not increase significantly
in patients without RS. Each box displays median and 95%
confidence interval. *p , 0.005.
Figure 4. Infarct size and LV function. Six weeks after AMI,
patients with RS (hatched boxes) had a larger infarct size (% 201T1
defect) and a lower radionuclide LV ejection fraction (LVEF) than
patients without RS (open boxes). Patients with RS had also a
larger predischarge LV end-systolic volume index (LVESVi).
Each box displays median and 95% confidence interval. *p 5
0.001; †p 5 0.004.
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Clinical relevance of the reperfusion syndrome. Al-
though the severe impairment of CVR in patients with RS
was transient, it was associated with larger infarct size and
poor recovery of LV function. Previous studies using myo-
cardial contrast echocardiography (32), positon emission
tomography (33) and videodensitometry (27) have demon-
strated that the preservation of an intact microcirculation in
the reperfused myocardium is a prerequisite for myocardial
salvage (34). More recently, Neumann et al. (26) reported
serial measurements of coronary flow reserve using a Dopp-
ler guidewire in 19 AMI patients who underwent primary
PTCA and stent implantation (26). They found in 13
patients an improvement of flow reserve in the first hour
after reperfusion, whereas six patients showed an early
decrease in flow reserve and tended to have larger enzymatic
infarct size. Whether this early decrease of flow reserve can
be related to the RS remains to be determined.
Study limitations. The main limitation of this study was
that the larger infarct size and more depressed LV function
observed in patients with RS may have been influenced not
only by the lower CVR found in these patients, but also by
several baseline clinical characteristics known to determine
infarct size. However, only patients with an occluded
proximal or mid-LAD were included in this study, and
baseline ST elevation was similar in patients with and
without RS, suggesting that the areas at risk were in the
same range. The lower collateral flow grade in patients with
RS certainly contributed to the severity of myocardial
infarction. Paucity of collateral flow has been related to the
amplitude of baseline ST segment elevation (35). Whether
it may also account for acute ST changes upon reperfusion
is unknown. Finally, pain-to-TIMI 3 time was similar in
the two groups.
Another limitation is that CVR, the parameter chosen to
relate RS to microcirculatory dysfunction, is dependent
upon several factors other than microcirculation, such as
hemodynamic variables (36) and residual stenosis of the
conduit artery (25). However, there was no difference in
heart rate, mean arterial blood pressure and residual stenosis
among groups, both at initial and predischarge angiography.
In summary, this study demonstrated that the RS, which
frequently accompanies the brisk reopening of occluded
LADs during primary PTCA for AMI, is associated with
severe, transient and, at least in part, reperfusion-related
alteration of microcirculatory function. Patients with RS
may benefit from adjuvant therapies aimed at improving
myocardial reperfusion, e.g., adenosine (37) or abciximab
(38).
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